Harrow (HROW) Goodwill & Intangibles (2014 - 2026)
Harrow's (HROW) quarterly Goodwill & Intangibles came in at $181.1 million in Q1 2026, down 13.2% year-on-year from $208.6 million in Q1 2025, and up 3.16% quarter-over-quarter from $175.5 million in Q4 2025.
Harrow (HROW) Goodwill & Intangibles (2014 - 2026) Analysis & Trends
Harrow's Goodwill & Intangibles history runs 13 years deep, the most recent figure standing at $181.1 million for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 13.2% year-over-year to $181.1 million in Q1 2026; TTM through Mar 2026 was $181.1 million, a 13.2% decrease from a year earlier, with the FY2025 full-year figure at $175.5 million, up 8325.64% from the prior year.
- Goodwill & Intangibles rose to $181.1 million in Q1 2026 per HROW's latest filing, from $175.5 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $209.1 million in Q3 2025 and bottomed at $1.5 million in Q2 2025.
- The 5-year median for Goodwill & Intangibles is $154.9 million (2024), against an average of $106.8 million.
- Biggest YoY gain for Goodwill & Intangibles was 8325.64% in 2025; the steepest drop was 99.05% in 2025.
- Year by year, Goodwill & Intangibles stood at $24.1 million in 2022, then soared by 564.7% to $159.9 million in 2023, then plunged by 98.7% to $2.1 million in 2024, then jumped by 8325.64% to $175.5 million in 2025, then increased by 3.16% to $181.1 million in 2026.
- Per Business Quant, the three latest HROW Goodwill & Intangibles figures stand at $181.1 million (Q1 2026), $175.5 million (Q4 2025), and $209.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Harrow | 1.56 Bn | 1.47 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 181.05 Mn |
| Dec 31, 2025 | 175.51 Mn |
| Sep 30, 2025 | 209.07 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 208.59 Mn |
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 189.27 Mn |
| Jun 30, 2024 | 154.88 Mn |
| Mar 31, 2024 | 171.96 Mn |
| Dec 31, 2023 | 159.91 Mn |
| Sep 30, 2023 | 162.70 Mn |
| Jun 30, 2023 | 2.14 Mn |
| Mar 31, 2023 | 152.32 Mn |
| Dec 31, 2022 | 24.06 Mn |
| Sep 30, 2022 | 2.21 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 16.88 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Sep 30, 2021 | 2.92 Mn |
| Jun 30, 2021 | 2.21 Mn |